Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants Clinical research trials and Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants. Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants clinical trial. Human subjects often obtain the finest healthcare possible for their Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "R" Clinical Trials Conditions > Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants



Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

For Condition: Graft Versus Host Disease
Status: Recruiting
Sponsor(s): FDA Office of Orphan Products Development , University of Michigan
Synopsis: This is a single arm dose escalation study of recombinant human keratinocyte growth factor given to patients undergoing allogeneic bone marrow transplantation who are at high risk for graft versus host disease (GVHD).
Details:
Eligibility:
Study Type:
  Interventional, Prevention, Non-Randomized, Open Label, Historical Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 3 Years/65 Years
Genders: Both
Protocol Entry Criteria: Eligible for full intensity bone marrow transplant (BMT) conditioning but who lack a 6/6 HLA idential sibling donor
Total Enrollment: 50

Location and Contact Information:

University of Michigan Cancer Center *Recruiting*
Ann Arbor,  Michigan,  48109
United States
Recruiting Christopher  Reynolds 734-936-8785


Additional Information:
Study ID Numbers:
  2146; 
Study Start Date: September 2002
Record last reviewed: June 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00056875

Other Graft Versus Host Disease Studies:
1. Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

2. Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

3. Phase I/II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation in Patients With High Risk Hemoglobinopathy

4. Visilizumab in Treating Patients With Graft-Versus-Host Disease Following Donor Stem Cell Transplantation

5. Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Related Studies:

Other Graft Versus Host Disease Clinical Trials
Other Michigan Clinical Trials
Other Ann Arbor Clinical Trials

Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants

Modify your Search

  Other Graft Versus Host Disease Clinical Trials
  Other Michigan Clinical Trials
  Other Ann Arbor Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103